×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Weyer Christian

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentApr 01, 2021Option Exercise$24.28461,11727,341Apr 05, 2021, 07:03 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentFeb 27, 2021Option Exercise$21.663577,73327,387Mar 02, 2021, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentDec 31, 2020Option Exercise$24.7077919,24115,198Jan 05, 2021, 07:01 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentJan 01, 2021Option Exercise$24.70541,33415,144Jan 05, 2021, 07:01 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 27, 2020Option Exercise$37.2735713,30515,977Nov 30, 2020, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentOct 01, 2020Option Exercise$42.08461,93616,334Oct 05, 2020, 07:02 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentAug 27, 2020Option Exercise$48.8135717,42516,380Aug 31, 2020, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentJul 01, 2020Option Exercise$46.52462,14016,737Jul 06, 2020, 07:03 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentMay 27, 2020Option Exercise$74.4335726,57216,783May 29, 2020, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentApr 27, 2020Sale$85.9518115,55717,140Apr 29, 2020, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentApr 01, 2020Option Exercise$58.40462,68617,321Apr 03, 2020, 07:08 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentFeb 27, 2020Sale$85.9347040,38517,480Feb 28, 2020, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentJan 27, 2020Sale$94.0472367,99117,837Jan 27, 2020, 07:01 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentDec 31, 2019Option Exercise$123.9236445,10713,814Jan 03, 2020, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentJan 01, 2020Option Exercise$123.92546,69213,760Jan 03, 2020, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentDec 27, 2019Option Exercise$108.542,051222,60815,759Dec 30, 2019, 07:01 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 27, 2019Option Exercise$85.832,324199,47116,686Dec 02, 2019, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 25, 2019Sale$79.553,710295,12817,614Nov 27, 2019, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 26, 2019Option Exercise$79.568,746695,79120,132Nov 27, 2019, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 19, 2019Sale$85.001,550131,75015,759Nov 19, 2019, 07:01 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 13, 2019Sale$85.0094680,41017,309Nov 15, 2019, 07:01 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentOct 01, 2019Option Exercise$65.87463,03018,255Oct 03, 2019, 07:02 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentAug 27, 2019Option Exercise$60.5035721,59918,301Aug 29, 2019, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentJul 01, 2019Option Exercise$79.17463,64218,658Jul 03, 2019, 05:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentMay 27, 2019Option Exercise$87.8335731,35518,704May 29, 2019, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentApr 01, 2019Option Exercise$111.50465,12919,061Apr 03, 2019, 07:01 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentFeb 27, 2019Option Exercise$92.7636433,76519,440Mar 01, 2019, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentMar 01, 2019Sale$103.1633334,35219,107Mar 01, 2019, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentJan 01, 2019Option Exercise$100.7921521,67015,604Jan 03, 2019, 07:04 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 27, 2018Option Exercise$108.661,438156,25317,162Nov 29, 2018, 07:00 PM
ICPTINTERCEPT PHARMACEUTICALS, INC.Weyer ChristianEVP, Research & DevelopmentNov 29, 2018Sale$113.781,343152,80715,819Nov 29, 2018, 07:00 PM
FATEFATE THERAPEUTICS INCWeyer ChristianSee RemarksApr 13, 2015Option Exercise$1.3725,00034,25030,429Apr 14, 2015, 03:52 PM
FATEFATE THERAPEUTICS INCWeyer ChristianSee remarksApr 01, 2014Option Exercise$5.1915,47680,3907,738Apr 03, 2014, 12:55 PM
FATEFATE THERAPEUTICS INCWeyer ChristianSee remarksApr 02, 2014Option Exercise$5.194,52423,4942,262Apr 03, 2014, 12:55 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentAug 08, 2012Option Exercise$31.001,33941,509886Aug 10, 2012, 06:37 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentAug 08, 2012Option Exercise$31.0035911,1290Aug 10, 2012, 06:37 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentAug 08, 2012Option Exercise$31.0034,2071,060,4171,012Aug 10, 2012, 06:37 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentAug 08, 2012Option Exercise$31.007,974247,1943,159Aug 10, 2012, 06:37 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentJul 25, 2012Option Exercise$14.623957034,207Jul 26, 2012, 08:07 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentMar 01, 2012Sale$17.111,23121,06224,168Mar 02, 2012, 07:47 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentFeb 23, 2012Sale$17.032,51942,89924,597Feb 24, 2012, 05:03 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentFeb 08, 2012Sale$16.623,84363,85320,416Feb 10, 2012, 08:55 PM
AMLNAMYLIN PHARMACEUTICALS INCWeyer ChristianSVP, Research & DevelopmentNov 19, 2010Sale$13.421,31417,6343,357Nov 19, 2010, 08:06 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe